NCT03421132Active, not recruiting
Multiple Myeloma Molecular Monitoring Study
The Terry Fox Pan-Canadian Multiple Myeloma Molecular Monitoring Study
Source: ClinicalTrials.gov · Last updated 29 Jun 2025
Brief summary (registry, in English)
The investigators will track 250 multiple myeloma patients across Canada over time, using new lab tests to evaluate their blood and bone marrow, as they receive standard of care treatment. The main hypothesis is that these tests will allow clinicians to better diagnose and manage multiple myeloma, improving patients' quality of life overall.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 96 (actual)
- First submitted
- 22 Jan 2018
- Start date
- 20 Feb 2018
- Primary completion date
- 31 Dec 2024
- Lead sponsor
- Horizon Health Network
- Diseases
- Multiple myeloma
- NCT number
- NCT03421132
What you commit to
- Study type: Observational
- Participants enrolled: 96
- From 20 Feb 2018 to the primary completion date, 31 Dec 2024
- 9 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Ineligible for ASCT
- Does not consent to participate in MCRN database project
Who the study is looking for
- Ability to give informed consent
- Diagnosed with active multiple myeloma
- Consented to participation in Myeloma Canada Research Network (MCRN) database project
- Previously untreated and eligible for autologous stem-cell transplantation (ASCT)
Age in the registry: 19 years to 99 years · Sex: All · Does not accept healthy volunteers
Sites (9)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Tom Baker Cancer Centre Coordinator of this site? Confirm its status | Calgary | Canada | Unknown status |
| Cross Cancer Institute Coordinator of this site? Confirm its status | Edmonton | Canada | Unknown status |
| Queen Elizabeth II, Health Sciences Centre Coordinator of this site? Confirm its status | Halifax | Canada | Unknown status |
| Buland Mangukia Coordinator of this site? Confirm its status | Hamilton | Canada | Unknown status |
| McGill University Health Centre Coordinator of this site? Confirm its status | Montreal | Canada | Unknown status |
| Saint John Regional Hospital-Horizon Health Network Coordinator of this site? Confirm its status | Saint John | Canada | Unknown status |
| Princess Margaret Cancer Centre Coordinator of this site? Confirm its status | Toronto | Canada | Unknown status |
| Vancouver General Hospital Coordinator of this site? Confirm its status | Vancouver | Canada | Unknown status |
| CancerCare Manitoba Coordinator of this site? Confirm its status | Winnipeg | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.